top of page
PRESS
Phase 3 Heal-MI Study Published
San Francisco, July 5, 2023 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular and...
Jul 5, 20232 min read
Closings of Series C Financing Round
San Francisco, May 31, 2023 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular and...
May 31, 20232 min read
Recardio at BIO International Convention 2023
San Francisco, May 2, 2023 - Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for cardiovascular...
May 2, 20231 min read
bottom of page